1. Study of the use of vitamin K in neonates in France

   • A. P. Jonville-Bera
   • E. Autret

   CLINICAL TRIALS Pages: 333 - 337

2. A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients treated with psychotropic drugs

   • H. Bagheri
   • L. Schmitt
   • J. L. Montastruc

   PHARMACODYNAMICS Pages: 339 - 342

3. Salt enhances responsiveness of terminal aortic vascular bed to sympathetic activity

   • H. Shimamoto
   • Y. Shimamoto

   PHARMACODYNAMICS Pages: 343 - 349

4. Moxonidine and cognitive function: interactions with moclobemide and lorazepam

   • K. Wesnes
   • P. M. Simpson
   • H. Küppers

   PHARMACODYNAMICS Pages: 351 - 358

5. The negative mucosal potential: separating central and peripheral effects of NSAIDs in man

   • J. Lötsch
   • T. Hummel
   • G. Kobal

   PHARMACODYNAMICS Pages: 359 - 364

6. The clinical phcarmacology of single doses of otilonium bromide in healthy volunteers

   • J. A. Sutton
   • S. G. Kilminster
   • G. P. Mould

   PHARMACODYNAMICS Pages: 365 - 369

7. Pharmacokinetic and pharmacodynamic interaction of single oral doses of valsartan and furosemide

   • M. Bindschedler
   • P. Degen
   • G. Preiswerk

   PHARMACOKINETICS AND DISPOSITION Pages: 371 - 378

8. Transdermal nitroglycerin: clinical and pharmacokinetic consequences of renewing the patch and the application site

   • T. O. Klemsdal
   • H. H. Mundal
   • K. Gjesdal

   PHARMACOKINETICS AND DISPOSITION Pages: 379 - 381

9. Ketotifen pharmacokinetics in children with atopic perennial asthma

   • M. L. McFadyen
   • R. Miller
   • T. M. Ludden

   PHARMACOKINETICS AND DISPOSITION Pages: 383 - 386

10. Non-response to maprotiline caused by ultra-rapid metabolism that is different from CYP2D6?

    • S. V. Vormfelde
    • A. Bitsch
    • C. H. Gleiter

    PHARMACOKINETICS AND DISPOSITION Pages: 387 - 390

11. Genetic polymorphism of CYP2C19 and lansoprazole pharmacokinetics in Japanese subjects

    • H. Katsuki
    • C. Nakamura
    • M. Nakano

    PHARMACOKINETICS AND DISPOSITION Pages: 391 - 396

12. Comparison of pharmacokinetics and dynamics of two dosage regimens of foscarnet in AIDS patients with Cytomegalovirus retinitis

    • F. Castelli
    • L. Tomasoni
    • A. Hedman

    PHARMACOKINETICS AND DISPOSITION Pages: 397 - 401

13. Itraconazole moderately increases serum concentrations of oxybutynin but does not affect those of the active metabolite

    • E. Lukkari
    • A. Juhakoski
    • P. J. Neuvonen

    PHARMACOKINETICS AND DISPOSITION Pages: 403 - 406

14. Pharmacokinetics of cloxacillin in patients undergoing hip or knee replacement

    • E. Vinge
    • G. Nergelius
    • L. Lidgren

    PHARMACOKINETICS AND DISPOSITION Pages: 407 - 411

15. A comparison of EMIT and FPIA methods for the detection of cyclosporin A blood levels: does impaired liver function make a difference?

    • O. Witzke
    • U. Heemann
    • M. C. Michel

    PHARMACOKINETICS AND DISPOSITION Pages: 413 - 416

16. Dextromethorphan O-demethylation polymorphism in the Uruguayan population

    • F. Estevez
    • M. Giusti
    • J. Oxandabarat

    LETTER TO THE EDITORS Pages: 417 - 418

17. Is there any difference between daytime and nighttime debrisoquine metabolism?

    • R. Bordet
    • A. Belabbas
    • C. Libersa

    LETTER TO THE EDITOR Pages: 419 - 420